Zobrazeno 1 - 10
of 799
pro vyhledávání: '"Thrombosis / etiology"'
Autor:
Loïc Faucher, Benjamin Marchandot, Adrien Carmona, Mickael Ohana, Antonin Trimaille, Olivier Morel
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundBioprosthetic valve thrombosis is a complication of transcatheter aortic valve replacement (TAVR). It is believed to be platelet independent, mainly driven by contact phase activation, and more likely to be targeted by oral anticoagulant (O
Externí odkaz:
https://doaj.org/article/611d28d135f44821879c451d83384cd4
Autor:
Omer F. Eker, Boris Lubicz, Melissa Cortese, Cedric Delporte, Moncef Berhouma, Bastien Chopard, Vincent Costalat, Alain Bonafé, Catherine Alix-Panabières, Pierre Van Anwterpen, Karim Zouaoui Boudjeltia
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
IntroductionThe flow diverter stent (FDS) has become a first-line treatment for numerous intra-cranial aneurysms (IAs) by promoting aneurysm thrombosis. However, the biological phenomena underlying its efficacy remain unknown. We proposed a method to
Externí odkaz:
https://doaj.org/article/b8ae591ed5a74566a0951f6dc05cdbc3
Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. When a blood vessel is injured, the body uses platelets and fibrin to form a blood clot, because the first step in repair
Autor:
Coughlan, J J, Räber, Lorenz, Brugaletta, Salvatore, Kufner, Sebastian, Maeng, Michael, Jensen, Lisette Okkels, Ortega-Paz, Luis, Bär, Sarah, Laugwitz, Karl-Ludwig, Madsen, Morten, Heg, Dik, Aytekin, Alp, Windecker, Stephan, Olesen, Kevin Kris Warnakula, Sabaté, Manel, Kastrati, Adnan, Cassese, Salvatore
Publikováno v:
Coughlan, J J, Räber, L, Brugaletta, S, Kufner, S, Maeng, M, Jensen, L O, Ortega-Paz, L, Bär, S, Laugwitz, K-L, Madsen, M, Heg, D, Aytekin, A, Windecker, S, Olesen, K K W, Sabaté, M, Kastrati, A & Cassese, S 2023, ' Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents : Insights From the DECADE Cooperation ', Circulation, vol. 147, no. 7, pp. 575-585 . https://doi.org/10.1161/CIRCULATIONAHA.122.062049
Background: Although some studies have investigated sex-related outcomes up to 5 years after percutaneous coronary intervention (PCI), analyses at longer follow-up (ie, to 10 years) in large cohorts treated exclusively with drug-eluting stent (DES) p
Autor:
Zwart, Bastiaan, Bor, Willem Lambertus, de Veer, Anne Johanna Wilhelmina Maria, Mahmoodi, Bakhtawar Khan, Kelder, Johannes Christiaan, Lip, Gregory Y.H., Bhatt, Deepak L., Cannon, Christopher P., Ten Berg, Jurriën Maria
Publikováno v:
Eurointervention, 18(4), E292-e302. Europa Digital & Publishing
Zwart, B, Bor, W L, de Veer, A J W M, Mahmoodi, B K, Kelder, J C, Lip, G Y H, Bhatt, D L, Cannon, C P & Ten Berg, J M 2022, ' A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention : a post hoc analysis of the RE-DUAL PCI trial ', EuroIntervention, vol. 18, no. 4, pp. e292-e302 . https://doi.org/10.4244/EIJ-D-21-00165
Zwart, B, Bor, W L, de Veer, A J W M, Mahmoodi, B K, Kelder, J C, Lip, G Y H, Bhatt, D L, Cannon, C P & Ten Berg, J M 2022, ' A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention : a post hoc analysis of the RE-DUAL PCI trial ', EuroIntervention, vol. 18, no. 4, pp. e292-e302 . https://doi.org/10.4244/EIJ-D-21-00165
BACKGROUND: Current guidelines recommend treating atrial fibrillation (AF) patients who undergo percutaneous coronary intervention (PCI) with triple antithrombotic therapy (TAT) for up to one month in patients at high thrombotic risk. It is unclear h
Autor:
Nils Skajaa, Jan P. Vandenbroucke, Claus Ziegler Simonsen, Henrik Toft Sørensen, Kasper Adelborg
Publikováno v:
Skajaa, N, Vandenbroucke, J, Simonsen, C Z, Toft Sørensen, H T & Adelborg, K 2023, ' Thromboembolic events, bleeding, and mortality in patients with cerebral venous thrombosis : a nationwide cohort study ', Blood Advances, vol. 7, no. 10, pp. 2070–2081 . https://doi.org/10.1182/bloodadvances.2022008622
Cerebral venous thrombosis (CVT) predominantly affects young to middle-aged women. Scarce data exist regarding the long-term prognosis. We examined the clinical course of patients with CVT overall and according to their age and sex. Using Danish regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75d53aad883e3b4aa9f200a88a71c7ab
https://pure.au.dk/portal/da/publications/thromboembolic-events-bleeding-and-mortality-in-patients-with-cerebral-venous-thrombosis(6c139269-93e3-41ca-bc4a-b546ca4f0d78).html
https://pure.au.dk/portal/da/publications/thromboembolic-events-bleeding-and-mortality-in-patients-with-cerebral-venous-thrombosis(6c139269-93e3-41ca-bc4a-b546ca4f0d78).html
Autor:
Suraj Wasudeo Nagre
Publikováno v:
Indian Journal of Vascular and Endovascular Surgery, Vol 3, Iss 1, Pp 7-10 (2016)
We performed this retrospective study to analyze our strategies for managing and surgically treating brachial artery injuries. Twenty patients with traumatic brachial artery injuries underwent surgery at our institution, from May 2013 to January 2016
Externí odkaz:
https://doaj.org/article/493f437720d54820945df3ab07004e84
Autor:
Radhoe, Sumant P, Veenis, Jesse F, Jakus, Nina, Timmermans, Philippe, Pouleur, Anne-Catherine, Rubís, Pawel, Van Craenenbroeck, Emeline M, Gaizauskas, Edvinas, Barge-Caballero, Eduardo, Paolillo, Stefania, Grundmann, Sebastian, D'Amario, Domenico, Braun, Oscar Ö, Gkouziouta, Aggeliki, Planinc, Ivo, Samardzic, Jure, Meyns, Bart, Droogne, Walter, Wierzbicki, Karol, Holcman, Katarzyna, Flammer, Andreas J, Gasparovic, Hrvoje, Biocina, Bojan, Lund, Lars H, Miličić, Davor, Ruschitzka, Frank, Cikes, Maja, Brugts, Jasper J
Publikováno v:
ESC heart failure
ESC heart failure, San Francisco : Wiley, 2023, vol. 10, iss. 2, p. 884-894
ESC heart failure, 10(2), 884-894. The Heart Failure Association of the European Society of Cardiology
ESC heart failure, San Francisco : Wiley, 2023, vol. 10, iss. 2, p. 884-894
ESC heart failure, 10(2), 884-894. The Heart Failure Association of the European Society of Cardiology
AIMS: Use of left ventricular assist devices (LVADs) in older patients has increased, and assessing outcomes in older LVAD recipients is important. Therefore, this study aimed to investigate associations between age and outcomes after continuous-flow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d21397b7e83ef09ce6515ca99ee5000
Autor:
Nouhravesh, Nina, Sindet-Pedersen, Caroline, Kümler, Thomas, Schou, Morten, Lamberts, Morten K, Højen, Anette Arbjerg
Publikováno v:
Nouhravesh, N, Sindet-Pedersen, C, Kümler, T, Schou, M, Lamberts, M K & Højen, A A 2022, ' "No one told me anything about it and I cannot explain it" : Illness perception in symptomatic and asymptomatic patients with cancer-associated thrombosis ', Thrombosis Research, vol. 220, pp. 125-130 . https://doi.org/10.1016/j.thromres.2022.10.013
Nouhravesh, N, Sindet-Pedersen, C, Kümler, T, Schou, M, Lamberts, M K & Højen, A A 2022, ' “No one told me anything about it and I cannot explain it” : Illness perception in symptomatic and asymptomatic patients with cancer-associated thrombosis ', Thrombosis Research, vol. 220, pp. 125-130 . https://doi.org/10.1016/j.thromres.2022.10.013
Nouhravesh, N, Sindet-Pedersen, C, Kümler, T, Schou, M, Lamberts, M K & Højen, A A 2022, ' “No one told me anything about it and I cannot explain it” : Illness perception in symptomatic and asymptomatic patients with cancer-associated thrombosis ', Thrombosis Research, vol. 220, pp. 125-130 . https://doi.org/10.1016/j.thromres.2022.10.013
INTRODUCTION: Patients with cancer, have reported cancer-associated thrombosis (CAT), a distressing event in their overall illness. However, whether the clinical presentation of CAT; symptomatic versus asymptomatic, impacts illness perception is poor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f758e23d96bcf3cca549459bcaf3cfc6
https://vbn.aau.dk/ws/files/505650000/Nouhravesh_et_al._2022_._No_one_told_me_anything_about_it_and_I_cannot_explain_it_Illness_perception_in_symptomatic_and_asymptomatic_patients_with_cancer_associated_thrombosis.pdf
https://vbn.aau.dk/ws/files/505650000/Nouhravesh_et_al._2022_._No_one_told_me_anything_about_it_and_I_cannot_explain_it_Illness_perception_in_symptomatic_and_asymptomatic_patients_with_cancer_associated_thrombosis.pdf
Autor:
Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Rajko Kusec
Publikováno v:
Leukemia Research
Volume 119
Volume 119
Primary myelofibrosis (PMF), post-polycythemia vera (post-PV) and post-essential thrombocythemia (post-ET) secondary myelofibrosis (SMF) are chronic myeloproliferative neoplasms (MPNs) characterized by bone marrow fibrosis, splenomegaly and debilitat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dfd57625258718458811a60fa6de5d0
https://urn.nsk.hr/urn:nbn:hr:105:524953
https://urn.nsk.hr/urn:nbn:hr:105:524953